The Impact of the COVID-19 Pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini

Int J Public Health. 2022 Oct 26:67:1605225. doi: 10.3389/ijph.2022.1605225. eCollection 2022.

Abstract

Objectives: We investigated the impact of COVID-19 on tuberculosis (TB) case notification and treatment outcomes in Eswatini. Methods: A comparative retrospective cohort study was conducted using TB data from eight facilities. An interrupted time series analysis, using segmented Poisson regression was done to assess the impact of COVID-19 on TB case notification comparing period before (December 2018-February 2020, n = 1,560) and during the pandemic (March 2020-May 2021, n = 840). Case notification was defined as number of TB cases registered in the TB treatment register. Treatment outcomes was result assigned to patients at the end of treatment according to WHO rules. Results: There was a significant decrease in TB case notification (IRR 0.71, 95% CI: 0.60-0.83) and a significant increase in death rate among registrants during the pandemic (21.3%) compared to pre-pandemic (10.8%, p < 0.01). Logistic regression indicated higher odds of unfavorable outcomes (death, lost-to-follow-up, and not evaluated) during the pandemic than pre-pandemic (aOR 2.91, 95% CI: 2.17-3.89). Conclusion: COVID-19 negatively impacted TB services in Eswatini. Eswatini should invest in strategies to safe-guard the health system against similar pandemics.

Keywords: COVID-19; Eswatini; interrupted time series; retrospective cohort study; tuberculosis.

MeSH terms

  • Antitubercular Agents / therapeutic use
  • COVID-19* / epidemiology
  • Eswatini
  • Humans
  • Pandemics
  • Retrospective Studies
  • Treatment Outcome
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology

Substances

  • Antitubercular Agents